Francisco José Muruzábal-rekin lankidetzan egindako argitalpenak (14)

2024

  1. Biochemical and biomechanical characterization of an autologous protein-based fibrin sealant for regenerative medicine

    Journal of Materials Science: Materials in Medicine, Vol. 35, Núm. 1

2023

  1. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells

    Current Eye Research, Vol. 48, Núm. 5, pp. 456-464

  2. Biological and Adhesive Properties of an Autologous Protein-Based Fibrin Sealant for Ophthalmological Applications

    Translational Vision Science and Technology, Vol. 12, Núm. 11

  3. Development of a new plasma rich in growth factors membrane with improved optical properties

    Annals of Anatomy, Vol. 248

  4. PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

2022

  1. Differential Protein Content between Fresh and Freeze-Dried Plasma Rich in Growth Factors Eye Drops

    Biomolecules, Vol. 12, Núm. 9

  2. Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases

    Bioengineering, Vol. 9, Núm. 10

  3. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 1, pp. 31-45

2021

  1. Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology

    Experimental Eye Research, Vol. 203

  2. Membrane of plasma rich in growth factors in primary pterygium surgery compared to amniotic membrane transplantation and conjunctival autograft

    Journal of Clinical Medicine, Vol. 10, Núm. 23

  3. Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy

    Medicine, Vol. 100, Núm. 3, pp. e24139

  4. Proteomic characterization of plasma rich in growth factors and undiluted autologous serum

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  5. Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditions

    European Journal of Ophthalmology, Vol. 31, Núm. 2, pp. 354-360

  6. Use of plasma rich in growth factors and regenerating agent matrix for the treatment of corneal diseases

    Vision (Switzerland), Vol. 5, Núm. 3